Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K DECEMBER 31, 2009 - PROGENICS PHARMACEUTICALS INC | form10_k12312009.htm |
| EX-32.2 - EXHIBIT 32.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_212312009.htm |
| EX-32.1 - EXHIBIT 32.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex32_112312009.htm |
| EX-31.1 - EXHIBIT 31.1 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_112312009.htm |
| EX-31.2 - EXHIBIT 31.2 CERTIFICATION - PROGENICS PHARMACEUTICALS INC | ex31_212312009.htm |
| EX-10.33 - EXHIBIT 10.33 TERMINATION AND TRANSITION AGREEMENT - PROGENICS PHARMACEUTICALS INC | ex10_3312312009.htm |
Exhibit 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statements on Form
S-3 (Nos. 333-130913, 333-130912) and Form S-8 (Nos. 333-52277,
333-120508, 333-124910, 333-143670, 333-143671, 333-151711,
333-160389, 333-160392) of Progenics Pharmaceuticals, Inc. of our report dated
March 10, 2010 relating to the financial statements, and the effectiveness
of internal control over financial reporting, which appears in this
Form 10-K.
|
/s/
PricewaterhouseCoopers LLP
|
|
|
New
York, New York
|
|
|
March 10, 2010
|